Pharmacogenomics Technology Market Overview, Challenges and Growth Opportunities Analysis till 2025

Posted on 2021-05-28 by researchinsights in Healthcare // 0 Comments

San Jose, California , USA, May 28, 2021 — /EPR Network/ —

The scope of the global Pharmacogenomics Technology Market was appreciated by US$ 5.62 billion in 2016 and it is likely to reach US$ 18.3 billion during the forecast period. This could be attributed to growth in geriatric population, prevalence of chronic diseases like HIV, tuberculosis, and cancer, increase in awareness amongst the patients regarding personalized therapy, and adoption of pharmacogenomics by loads of healthcare professionals.

The pharmacogenomics technology market is also likely to get bolstered technological advancements related to molecular diagnostics. At the same time, there is a dearth on the part of highly skilled and trained healthcare professionals in conducting pharmacogenomics diagnostics tests. Besides, emerging economies need to think twice before affirming pharmacogenomics tests as initial as well as operating costs are high. Governments herein do struggle with funding on this count.

Request a Sample Copy of Pharmacogenomics Technology Market Report @ https://www.millioninsights.com/industry-reports/pharmacogenomics-technology-market/request-sample

Therapeutic Area Outlook (Revenue, USD Million; 2014 – 2025)

Oncology
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others

Technology Outlook (Revenue, USD Million; 2014 – 2025)

PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others

The players contributing to the pharmacogenomics technology market include OPKO Health, Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceutical Industries Ltd., Dynamic DNA Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., One Ome LLC, Empire Genomics, LLC, and Illumina, Inc.

Access Pharmacogenomics Technology Market Report with TOC @ https://www.millioninsights.com/industry-reports/pharmacogenomics-technology-market

North America rules the roost; thanks to extensive investment in healthcare by the U.S. Europe comes in second due to Belgium and Denmark being on the top pedestal with respect to healthcare. Asia Pacific is expected to grow at the fastest pace owing to increase in awareness among the economies like India and China regarding healthcare. LATAM will also catch up due to presence of Brazil; followed by MEA. In fact, MEA would be more vigilant on this count; due to the figures released by WHO. It says that over 50% of the diseases mentioned above occur in sub-Saharan Africa.

Visit Our Blog: https://marketreportsassistance.wordpress.com

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Matched content

Editor’s pick